The product can not be sold in a country where it is illegal.

The best way to purchase NM2201

Specification
Product Name: NM-2201
IUPAC Name: naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
Other Names: CBL-2201
Cas Number: 837122-21-7
Molecular Formula: C24H22FNO2
Molar Mass: 375.16
Effect: stimulant, psychedelic, cannabinoid
Purity of the substance: 99.6%
Physical properties: powder
100g
$630
200g
$850
300g
$970
500g
$1500
1000g
$2300
2000g
$3700
5000g
$6500
10000g
$11000
The best way to purchase NM2201
In Stock
Delivery:

- FREE shipping, 6-7 days delivery time
- Inner sending exist.
The main payment option is Bitcoin. As extra ways WU, MG.
We alwayse provide FREE samples of Top products with the main order.

Loyalty program exist, second order will be - 5%OFF

Safely work only with us! We provide - re-shipment guarantees.

Here you'll discover unused lawful items of immaculate quality.

Some time recently purchase if you don't mind make beyond any doubt that the items beneath your curiously are lawful in your country.

We do not offer a pharmaceutical items or beneath control items.

The best way to get legal high with us to buy NM2201 for sale

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity. It has an IC50 of 3.2 nM at CB1 and 7.4 nM at CB2.

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity. NM-2201 is a structural analog of PB-22. NM-2201 was also demonstrated to be an effective analgesic in several rodent behavioral models that show drug addiction potential.

CBL-2201 is a cannabinoid that displays analgesic properties, as well as some cardiovascular effects.

NM-2201 is one of the many synthetic cannabinoids used in "research chemical" blends.

Researchers have discovered a new drug similar to an existing pain-relieving medication.

NM-2201 is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related CB agonist 5F-PB-22 and NNE1, which are both unselectively bound to CB1 and CB2 receptors with low affinity. NM-2201 or CBL-2201 can be extremely potent and highly toxic if administered in large doses.

CBL-2201 is a synthetic cannabinoid that binds to Cannabinoid receptors, CB1 and CB2. Its potency can be extremely toxic, and high doses can result in death.


Looking for online research chemicals NM2201 vendor USA


NM-2201 is an indole-based synthetic cannabinoid that binds to CB1 and CB2 receptors.

NM-2201 or CBL-2201 are synthetic marijuana drugs sold as alternatives to THC, one of the active chemicals in natural Cannabis sativa.

CBL-2201 is one of the new-generation synthetic cathinones used to imitate cocaine and MDMA.

NM-2201 is a potent full agonist at the CB1 and CB2 receptors but with a significantly higher affinity for CB2 than CB1. It has poor oral bioavailability and is insoluble in water.

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1

NM-2201 (also known as CBL-2201) is an indole[1]phenylacetylindazole[2][3] that presumably has similar properties to the closely related 5F-PB-22, NNE1. NM2201 is a full agonist of the CB1 and CB2 receptors in mouse striatum tissue.

NM-2201 is a synthetic cannabinoid derivative with similar properties to other related compounds, such as 5F-PB-22 and NNE1, which are full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity.

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity. This product is intended for laboratory research only. It is not intended for human consumption or household use.

NM-2201 is a synthetic cannabinoid derivative developed by researchers at Clemson University. NM-2201 was first assessed for its pharmacology in 2014 when it was found to be a full agonist of the CB1 and CB2 receptors with low nanomolar affinity. The drug has been documented to induce seizures following administration in rodents through unknown mechanisms, which may involve NMDA receptor antagonism.


100g $600

200g $690

1kg $1890

500g $1200

100g $390

1kg $1690

1kg $1590

1kg $1690

1kg $1890

1kg $1590

100g $490

100mg $840